dismiss

Clean Sweep Live Auction on Wed. May 1st. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Ultrasound Homepage

Breaking barriers in Alzheimer’s disease with focused ultrasound Researchers at Sunnybrook in Toronto are closing the therapeutic gap

Purchasing insights for cardiac ultrasound Guidance from the market experts at MD Buyline

Trice Imaging connects imaging devices of large chain healthcare provider Aleris Patients and physicians can view images on laptops, cell phones

New ultrasound tech could help detect pediatric congenital heart disease Visualizes structure and blood flow of babies' hearts

Getting to the heart of cardiac ultrasound technology From premium systems to point of care, an expanding market

Echocardiogram should play role in patient selection for transcatheter mitral valve repair, says study New study highlighted at ACC

Emerging applications of contrast-enhanced ultrasound in pediatric imaging Discussing the benefits of an emerging technology

Petition calls for removal of 'black box' designation for ultrasound contrast agents Argues that UCAs are safe and "black box" misrepresents risk

Hitachi unveils new CT and ultrasound solutions at ECR Standard version of SCENARIA VIEW and three new Arietta ultrasound solutions

Probo Medical acquires Trisonics Now offers an extensive ultrasound service division

Concept illustration of a cart based
ultrasound and TAEUS platform
courtesy: ENDRA

GE and ENDRA extend agreement to advance liver ultrasound

by John W. Mitchell , Senior Correspondent
The increasing worldwide incidence of liver disease, driven by obesity, diabetes and hepatitis, is pushing imaging companies to develop new technology for earlier diagnosis. ENDRA has renewed an agreement with GE Healthcare to continue work on a standard CT application.

“Over one billion people are affected by fatty liver disease (NAFLD), which can progress to inflammation (NASH), then fibrosis scarring, then cirrhosis or cell death and then to cancer,” Francois Michelon, CEO at ENDRA Life Sciences told HCB News. “There are no practical tools for diagnosing NAFLD and NASH.”

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



To remedy this, EDRA has developed Thermo Acoustic Enhanced Ultrasound (TAEUS) that will enable standard ultrasound to detect such liver diseases in the early stage, while it is still reversible. Currently, the company said, ultrasound can only indicate liver diseases in the late stages.

ENDRA and GE Healthcare are working to deploy the technology in Europe by the end of 2018. Michelon said the expected cost of the unit would be about $40,000.

“We believe that ENDRA's technology has the potential to bring significant new capabilities to ultrasound - which aligns well with GE Healthcare's mission of increasing access to high-quality, cost-effective health care,” said Brian McEathron, GE Healthcare's vice president and general manager for General Imaging Ultrasound. “We're very excited about completing the final steps toward commercialization of ENDRA's TAEUS fatty liver product."

Michelon said TAUES is safer and more economical than other standard protocols. MR/CT technology, he noted, is expensive to acquire at between $1-3 million. Surgical biopsy is another alternative, but the procedure is also expensive, painful and carries the risk of complications. And blood liver enzyme level testing is unreliable he said, with about half of all NAFLD patients testing normal.

“The key benefit of ENDRA's technology is that it leverages conventional ultrasound, which is widely accepted as safe, cost-effective, easy-to-use, and broadly available. This broadens access to better health care,” said Michelon.

TAEUS will also offer more widespread diagnostic testing for liver disease, according to Michelon. Physicians will gain a new, cost-effective, and safe tool to address the growing crisis of liver disease. They will be able to deliver better health care to more people in clinics, community hospitals, private practices, patient bedsides – wherever ultrasound is used.

“By diagnosing NAFLD earlier on ultrasound, insurers will start reducing downstream costs of advanced liver disease, such as expensive inpatient care and liver transplants, as well as avoid costs of more expensive diagnostic tools such as CT and MR,” said Michelon.

ENDRA is also developing several other software applications to enhance ultrasound. This includes an application to indicate tissue temperature with ultrasound during energy-based surgeries to treat cancer and heart conditions.

Ultrasound Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED